title: Duration of asthma and lung function in life-long nonsmoking adults.
abstract: BACKGROUND
  The airways of adult or elderly asthmatics are likely candidates for airway remodeling, resulting in persistent airflow obstruction. This population can provide a good model for cross-sectional evaluation of the effect of asthma duration on airflow.
  
  
  METHODS
  We evaluated postbronchodilator airflow and lung volumes at baseline and after a short course of oral prednisone in a group of 42 never-smokers with persistent mild or moderate asthma aged 55 years or older. Patients were grouped as having short duration asthma (SDA, <14 years) or long duration asthma (LDA, > or =14 years) according to the median duration of the disease (14 years) of the sample.
  
  
  RESULTS
  There were no significant differences in patient characteristics or asthma severity indices between the groups. After a short course of prednisone, forced expiratory volume in 1 second (FEV1) and the ratio of FEV to forced vital capacity (FVC) were significantly higher for the SDA group. Only 3 patients presented persistent airflow limitation (FEV1/FVC% < 75%). An inverse correlation was demonstrated between duration of asthma and postbronchodilator FEV1 (% predicted) (r = -0.43, P = .01) and FEV1/FVC% (r = -0.50, P = .003).
  
  
  CONCLUSIONS
  Our data show a close relationship between duration of disease and loss of lung function, supporting the concept of asthma as a slow, progressive disease at least among those patients with a mild-to-moderate severity. Permanent airflow obstruction in mild or moderate asthma is unusual, but can occur in a small number suffering from the disease for years.
authors: Allergology Section, Lung Function Laboratory, Hospital Virgen del Camino, Pamplona, Spain. jmolaguibel@telefonica.net
authors: J M
authors: JM
authors: Olaguibel Rivera
authors: M J
authors: MJ
authors: Alvarez-Puebla
authors: M
authors: M
authors: Puy Uribe San Martín
authors: M L
authors: ML
authors: Tallens Armand
mesh_terms: D000368:Aged; D001249:Asthma / Q000503:physiopathology*; D003430:Cross-Sectional Studies; D018450:Disease Progression; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D008297:Male; D008875:Middle Aged; D029424:Pulmonary Disease, Chronic Obstructive / Q000503:physiopathology*; D013997:Time Factors; D014797:Vital Capacity